Results 11 to 20 of about 19,931 (150)
Introduction. Advances in hemophilia care and treatment have led to increases in the life expectancy among hemophiliacs. As a result, persons with hemophilia are reaching an older age and experiencing various age-related health conditions never seen ...
Aroub A. Khleif +3 more
doaj +1 more source
IntroductionObesity is associated with a higher risk of abortion in women undergoing in vitro fertilization (IVF). Whether thrombophilia amplifies this risk is currently unclear.
Matteo Candeloro +8 more
doaj +1 more source
Objective There are numerous studies reporting a disproportionally high prevalence of thrombophilia in women with a history of recurrent miscarriage (RM), which has led to overdiagnosis and treatment without an improvement in clinical outcomes.
Hassan Shehata +7 more
doaj +1 more source
Thrombophilia identified as a risk factor for thrombogenesis in cancer patients
Aim: to assess a rate and range of genetic and acquired thrombophilia in onco-gynecologic patients with ovarian cancer, uterine corpus cancer and cervical cancer.Materials and Мethods.
A. V. Vorobev +4 more
doaj +1 more source
Pregnancy is hypercoagulable state. The field of thrombophilia; the tendency to thrombosis, has been developed rapidly and has been linked to many aspects of pregnancy.
Kupferminc Michael J
doaj +1 more source
Features of pregnancy course in patients with thrombophilia and abnormal placenta location
Aim: to identify inherited and acquired thrombophilia as well as features of pregnancy course in women with abnormal placenta location.Materials and Methods.
V. B. Zubenko, A. I. Lovkova
doaj +1 more source
Direct oral anticoagulants (DOACs) are widely used in several indications, but data on their efficacy and safety in individuals affected by severe inherited thrombophilia, yet without any personal history of thrombosis, is lacking.
Evelien Krumb, Cedric Hermans
doaj +1 more source
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis
Thomas G. Deloughery +4 more
doaj +1 more source
Whole-exome sequencing in evaluation of patients with venous thromboembolism
: Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, protein S, or ...
Eun-Ju Lee +25 more
doaj +1 more source
The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia
Thrombophilia is a multifactorial disorder that arises from the interaction of acquired and genetic risk factors. Despite the significant efforts made to understand the etiology of this disease, there are still a certain number of patients suffering from
Aradjanski M. +6 more
doaj +1 more source

